Overexpression of numerous growth factor receptors [54–57] and constitutive activation of integrins [56] and activators of integrins [58] in prostate cancer increase FAK functions and increase metastasis in immunodeficient mouse models. Here, PTK2 is linked to prostate carcinoma.